Read the label.
Keep the context.
THE SOURCE REGISTER
Primary product pages establish what a company says. Published studies and authoritative guidance answer different questions. Individual access dates are recorded below; they are not claims about publication or formulation dates.
Provider page
PDP describes copper peptide 2% and nighttime repair/firm positioning. Linked offer now supplies plan totals and a fragrance-free base claim; see separate offer source. Full ingredient base, peptide identity, percentage basis and finished-product clinical superiority remain unverified.
Accessed 2026-10-05
Manufacturer page
Official US 30 mL selection displayed $32 on October 5. The earlier $28.80 promotional capture is retained as historical research. Complete current ingredients and directions remain essential; no checkout or delivery test.
Accessed 2026-10-05
Manufacturer page
GHK-Cu/GHK descriptions, ingredient declaration and manufacturer study footnotes inspected. Full study reports were not independently appraised. Size choices are not interchangeable. Direct size selection confirmed $62 for 15 mL and $93 for 30 mL.
Accessed 2026-09-26
Manufacturer page
50 mL full size $69 and marked in stock. Full public ingredient list and study footnotes inspected; copper-peptide concentration not established. No checkout or wear test.
Accessed 2026-09-26
Published randomized study
Abstract reviewed: 13 completers in a post-laser setting. Objective between-group differences were not significant; patient-reported satisfaction favored GHK-Cu. Not a trial of the current reviewed products.
Accessed 2026-10-21
Regulatory guidance
Explains lack of FDA approval and premarket review for compounded drugs. General guidance, not a pharmacy inspection report.
Accessed 2026-09-25
Regulatory guidance
General ingredient-order rules, including the 1% or less exception and separate color-additive provisions. Not a determination about any particular product.
Accessed 2026-09-26
Regulatory guidance
Explains intended use, product claims and the distinction between cosmetics and drugs. No separate legal category for cosmeceuticals.
Accessed 2026-09-25
Dermatology guidance
General cosmetic home-testing and reaction guidance; medical patch testing is distinct. Page states last updated August 10, 2021; access date is not a new publication date.
Accessed 2026-09-26
Dermatology guidance
Sun protection, moisturizer, product directions and limiting irritation. Does not endorse a copper-peptide brand.
Accessed 2026-09-25
Dermatology guidance
General distinctions between gels, lotions, creams and ointments, plus dryness and sun-protection context. Not a sensory test of reviewed products.
Accessed 2026-09-25
Dermatology guidance
Context for dryness and changing skin; new or concerning lesions require appropriate assessment. Not evidence that copper peptides reverse hormonal changes.
Accessed 2026-09-25
Manufacturer record with access limits
Indexed official record inspected: 30 mL, 3% copper-peptide claim, €44.95 display and ingredient/warning text. Direct and TinyFish retrieval returned a generic store shell; regional indexed ingredient records differed. Current shipment formula, stock, US total and live offer remain unverified.
Accessed 2026-09-26
Manufacturer page
Ingredient list names hydrolyzed soy protein, cupric chloride, sodium salicylate and fragrance. Direct page shows $34–$67 range; exact option/volume mapping not established. Marketing mentions salicylic acid, while the declaration names sodium salicylate. Testimonials and procedure claims are not controlled evidence.
Accessed 2026-09-26
Device guidance
Product-specific device authorizations, risks and patient questions. Devices are not approved for delivering cosmetics or topical medications into skin. Does not establish a universal serum restart interval.
Accessed 2026-09-26
Cosmetic consumer guidance
Fragrance labeling, unscented masking ingredients and sensitivity questions. The complete fragrance composition may not be disclosed individually; no product-specific allergy finding is made.
Accessed 2026-09-26
Cosmetic consumer guidance
No federal standard or definition governs the cosmetic term hypoallergenic; it does not guarantee tolerance or represent FDA certification.
Accessed 2026-09-26
Nutrition guidance
Dietary copper roles, sources, deficiency and excess. Nutrition amounts and upper limits are not topical dosing rules, product absorption estimates, or evidence of a cosmetic result.
Accessed 2026-09-26
Manufacturer page
Selected standard 30 mL page displayed $25. Copper Palmitoyl Heptapeptide-14, not a verified GHK-Cu concentration; complete ingredient declaration, formula-change notice and brand-specific layering claims checked. No hands-on testing, independently appraised finished-product trial, vegan supply-chain audit or dermatologist-test protocol established.
Accessed 2026-09-27
Regulatory consumer guidance
General intended-use, hygiene, irritation and infection guidance. Does not establish eye-area suitability for any reviewed facial serum; source publication dates are distinct from this access date.
Accessed 2026-09-27
Regulatory consumer guidance
Explains lack of legal definitions for these phrases and differing scopes, including finished products, suppliers and historical testing. Does not audit a brand or certification.
Accessed 2026-09-27
Dermatology guidance
Minor-wound care and escalation guidance; not a trial of copper peptides or support for unapproved wound use.
Accessed 2026-09-27
Dermatology guidance
General pregnancy skin-care guidance; does not establish exact-product copper-peptide safety.
Accessed 2026-09-27
Dermatology guidance
Condition-specific eczema guidance illustrates nursing and application-site questions; not a copper-peptide regimen.
Accessed 2026-09-27
Provider sales page
Three-month $195 total/displayed $64.99 monthly; one-month $80/displayed $79.99. Provider now describes a fragrance-free base, no auto-billing, free shipping and nonapproval refund. Rounded monthly displays, cream/serum wording mismatch and unverified grade/bioavailability claims retained as limits. No transaction, review authenticity or finished-product efficacy audit.
Accessed 2026-10-05
Provider page
GHK-Cu 2%; inactive ingredient field remains an unfinished placeholder. $195 three-month billing/$64.99 monthly display or $79.99 monthly; automatic renewal. Provider evaluation and nonapproval refund described; pharmacy/testing claims not independently audited.
Accessed 2026-10-05
Official manufacturer information
Copper Palmitoyl Heptapeptide-14; 30% refers to a multi-peptide complex, not a copper concentration. US 30 mL displayed $95 on October 5; selected availability and final checkout need confirmation. Separate clinical and consumer footnotes; no full independent appraisal or injectable equivalence established.
Accessed 2026-10-14
Official manufacturer information
Manufacturer advertises 0.2% copper peptide; no independent concentration assay. Official product data: selected 30 mL $49; checkout and delivery untested. Before-and-after imagery attributed to consumer research; complete methods not independently appraised.
Accessed 2026-10-05
Official manufacturer information
Copper Tripeptide-1 is declared; six peptides is a count, not six disclosed concentrations. Single-product $25 display with backorder text in the capture; confirm selected availability. Manufacturer testing descriptions concern different endpoints; no universal tolerance guarantee.
Accessed 2026-10-05
Official manufacturer information
Copper Palmitoyl Heptapeptide-14 listed; exact amount not established. Selected standard 50 mL displayed $72; refill and other sizes are distinct offers. Manufacturer appearance claims; no independently appraised superiority or packaging lifecycle study.
Accessed 2026-10-05
Official manufacturer information
Copper Tripeptide-1 among six named peptides; individual amounts undisclosed here. Displayed $22.50 with sold-out/notification language; immediate fulfillment not established. Brand texture and exclusion claims are not an individual tolerance guarantee.
Accessed 2026-10-05
Official manufacturer information
Bis (Tripeptide-1) Copper Acetate declared; another peptide name differs between callout and full list. Official 1.0 oz listing $120; final delivered total unverified. Numerical manufacturer claims require their full study context; no independent full-report appraisal.
Accessed 2026-10-05
Official manufacturer information
Advertised 1% GHK-Cu complex; precise percentage basis not independently assayed. Displayed $30 one-time, with a separate subscription option and interval choices. Ingredient rationale and developer credentials do not establish a personal outcome.
Accessed 2026-10-05
Official manufacturer information
Combined 1.25% headline does not establish 1.25% pure copper peptide; Sodium DNA is separately described. India page ₹629 against ₹699 MRP; no US delivered price established. No independently appraised long-term prevention or comparative finished-product result.
Accessed 2026-10-05
Official manufacturer information
GHK-Cu, Argireline and Matrixyl 3000 descriptions do not disclose equivalent individual concentrations. No selected all-in price recorded; related-product prices must not be assigned to this serum. Ingredient studies do not establish the full blend’s performance or equivalence to procedures.
Accessed 2026-10-05
Official manufacturer information
Official listing names copper peptide and PDRN; exact species, amount and full declaration unresolved. Official v1 listing displayed $12 with pack choices; no verified unit-volume or delivered total. Sparse product record; no borrowed formula or finished-product trial claims.
Accessed 2026-10-05
Provider or pharmacy record
Provider advertises 0.5% and 3% GHK-Cu cream; selection requires clinician evaluation. 0.5% $99 first month; 3% $149 first month. Later charges and supplied quantity need confirmation. Provider claims and ingredient research do not establish superiority of either strength.
Accessed 2026-10-05
Provider or pharmacy record
Provider discusses GHK copper peptides for skin and hair; no universal preparation established. Complete individualized quote needed; medication, consultation and other fees are not established here. General provider article is not the evidence or dispensing label for every possible preparation.
Accessed 2026-10-05
Provider or pharmacy record
Official pharmacy record lists GHK-Cu 0.5%, 1% and 2%; no self-selection recommendation. No universal patient price or all-in telehealth fee established; request a complete quote. Pharmacy listing, clinical evaluation and FDA approval are separate questions.
Accessed 2026-10-05
Official manufacturer information
Several peptide ingredients described; no copper-peptide formulation established in this record. Selected 1 oz displayed $95; final transaction and usage duration unverified. Contour and lifting language needs finished-product evidence; no procedure equivalence established.
Accessed 2026-10-05
Official manufacturer information
Carnosine and collagen amino acids described; no copper-peptide concentration established. Installment figures are not the total price; selected complete offer must be confirmed. Banking is marketing language, not a verified permanent collagen reserve.
Accessed 2026-10-05
Official manufacturer information
Palmitoyl Tripeptide-38 and Acetyl Hexapeptide-8 listed; no copper formula established. Displayed $36.95 one-time or $33.26 subscription; recurring terms differ from a single purchase. Short elasticity-study footnote lacks a full independently appraised protocol in this review.
Accessed 2026-10-05
Official manufacturer information
Six pro-collagen peptides described; no named copper concentration established here. UK capture £58 with £49.30 promotion; not a US delivered-price quote. 34-person 15-minute and 31-person four-week summaries remain separate; full reports not appraised.
Accessed 2026-10-05
Official manufacturer information
19% peptide complex and 10% Argirelox are distinct descriptions, not verified 29% pure peptides. Official selected product data displayed $65; delivery and complete checkout not tested. Procedure-like branding does not establish an injectable-equivalent result.
Accessed 2026-10-05
Official manufacturer information
Peptide and ceramide names listed; no copper-peptide formula established. Selected bottle displayed $26; no fixed monthly supply or complete delivered total established. Manufacturer barrier and testing claims do not establish universal suitability.
Accessed 2026-10-05
Official manufacturer information
Copper Palmitoyl Heptapeptide-14 described within X50; other technology percentages are separate. Regional listing €15.80; no verified US delivered total. Supplier technology data and a delivery explanation are not a finished-serum outcome measurement.
Accessed 2026-10-05
Official manufacturer information
Copper Lysinate and Copper Tripeptide complexes are separate claims; do not add them into GHK-Cu strength. Selected 1 fl oz $199 one-time or $169.15 subscription; other sizes and intervals differ. Self-assessments, ingredient studies and neighboring-product results must not be merged.
Accessed 2026-10-05
Provider information
Catalog examined; no topical copper-peptide preparation confirmed. Provider statements are not independent performance verification.
Accessed 2026-10-05
Provider information
Campaign concerns weight care, not a copper cream. Auto-refill can be turned off before future orders; no account or cancellation test.
Accessed 2026-10-05
Provider shipping reference and supplied service information
Homepage shipping reference; customer service and payment details supplied for this review, without a checkout or timed support test
Accessed 2026-10-11
Provider shipping reference and supplied service information
Homepage shipping reference; customer service and payment details supplied for this review, without a checkout or timed support test
Accessed 2026-10-11
Official product or purchase terms
Public source checked for this editorial review; no product-use or transaction test.
Accessed 2026-10-14
Official product or purchase terms
Public source checked for this editorial review; no product-use or transaction test.
Accessed 2026-10-14
Official product or purchase terms
Public source checked for this editorial review; no product-use or transaction test.
Accessed 2026-10-14
Clinical background
Public source checked for this editorial review; no product-use or transaction test.
Accessed 2026-10-14
Official product or purchase terms
Public source checked for this editorial review; no product-use or transaction test.
Accessed 2026-10-14
Official product or purchase terms
Public source checked for this editorial review; no product-use or transaction test.
Accessed 2026-10-14
Official product or purchase terms
Public source checked for this editorial review; no product-use or transaction test.
Accessed 2026-10-14
Indexed primary study abstract
Accessed 2026-10-21
Indexed primary laboratory-study abstract
Accessed 2026-10-21
Indexed primary laboratory-study abstract
Accessed 2026-10-21
Author-posted primary full-text OCR; original table and figure layout not verified
Accessed 2026-10-21
Product prices, availability, ingredients, and directions can change. Our editorial method explains the limits of this public-source review.